Synthetic GLP-1 drugs are designed to mimic this process
GSH as a redox regulator in the brain In addition to its role in the antioxidant system, GSH also plays a critical role in regulating cellular redox status
Supplementing with supraphysiologic doses of single agents can produce oxidant injury
The safety results are as expected for a once-weekly GLP-1 receptor agonist
"I know I'm not the only one that feels this way when they go out." Doctors say he's onto something
In the context of clinical practice, it may be important to assess for symptoms of eating disorders/disordered eating behaviors, mood instability, and general psychosocial functioning as well as quality of life, social support, health behaviors, and readiness to change prior to the initiation of and throughout the course of GLP-1 treatment [30]